Home » Topics » BioWorld Science

BioWorld Science
RSS

Company Profile: Penwest

Jan. 21, 1998

Dynavax and Vical crosslicense DNA immunization technology

Jan. 21, 1998

Targeted cytotoxic LHRH analogues show potential as Rx for breast cancer

Jan. 21, 1998

Ribozyme, Parke-Davis intend to collaborate

Jan. 20, 1998

IL-12 offers new approach to BMT in leukemia patients

Jan. 20, 1998

BioTime lays groundwork for Japanese licensing of Hextend

Jan. 20, 1998

Controlled-release tramadol under development

Jan. 20, 1998

Pharmacopeia achieves milestone in collaboration with Daiichi

Jan. 20, 1998

Filgrastim reduces neutropenia and morbidity associated with AML treatment

Jan. 20, 1998

Preclinical efficacy results reported for Maruho's NSAID

Jan. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...